Apimeds Pharmaceuticals US Inc
APUS | AMEX
$2.88
-$0.33 (-10.28%)
At close: Oct 30, 2026, 3:59 PM ET
$3.14
+$0.26 (+9.03%)
Pre-market:
Nov 2, 2026, 6:10 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
PE Ratio | -2.98 | -1.83 | -3.26 | -3.79 | -2.47 |
PEG Ratio | 0.06 | -0.02 | -0.20 | 0.11 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.12 | -1.87 | 79.57 | -3.55 | -10.63 |
P/FCF Ratio | -1.99 | -3.46 | -4.04 | -5.66 | -3.08 |
P/OCF Ratio | -2 | -3.46 | -4.04 | -5.66 | -3.08 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | -0.44 | 8.37 | -0.92 | -1.68 |
Quick Ratio | 1.31 | 0.01 | 3.42 | 0.02 | 16.16 |
Current Ratio | 1.31 | 0.01 | 3.42 | 0.02 | 16.16 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -42.09 | -10.83 | -19.63 | -21.95 | -151.26 |
Return on Equity | -3.91% | 102.35% | -2.44K% | 93.70% | 430.32% |
Return on Assets | -3.66% | -10.65K% | -184.25% | -10.84K% | -596.06% |
Return on Invested Capital | -7.39% | 167.49% | -250.18% | 1.19K% | -631.20% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove APUS